ArticleThe Journal of dermatology2026

Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan.

Akira Yuasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.